IRRERA, Natasha
 Distribuzione geografica
Continente #
EU - Europa 3.866
NA - Nord America 3.389
AS - Asia 589
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 3
Totale 7.857
Nazione #
US - Stati Uniti d'America 3.368
IE - Irlanda 1.011
IT - Italia 908
SE - Svezia 827
PL - Polonia 671
CN - Cina 485
GB - Regno Unito 92
FI - Finlandia 81
DE - Germania 72
UA - Ucraina 68
BE - Belgio 51
VN - Vietnam 47
IN - India 35
AT - Austria 34
FR - Francia 29
CA - Canada 20
RU - Federazione Russa 9
KR - Corea 5
RO - Romania 4
AU - Australia 3
CL - Cile 3
EU - Europa 3
HK - Hong Kong 3
ID - Indonesia 3
EG - Egitto 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
MY - Malesia 2
NL - Olanda 2
SI - Slovenia 2
TR - Turchia 2
BG - Bulgaria 1
CH - Svizzera 1
ES - Italia 1
GH - Ghana 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
PA - Panama 1
SA - Arabia Saudita 1
Totale 7.857
Città #
Dublin 1.011
Chandler 778
Warsaw 671
Nyköping 447
Messina 427
Ashburn 285
Jacksonville 202
Beijing 152
Ann Arbor 147
Dearborn 144
Princeton 138
Medford 131
New York 113
Cambridge 97
Des Moines 95
Wilmington 63
Rome 62
Brussels 50
Boardman 47
Dong Ket 47
San Mateo 42
Lancaster 40
Woodbridge 40
Jinan 39
Shenyang 38
Houston 34
Vienna 34
Pune 31
Nanjing 27
Seattle 25
Fairfield 24
Los Angeles 22
Taizhou 20
Haikou 19
Tianjin 19
Ningbo 18
Washington 17
Trecastagni 16
Catania 15
Hebei 15
Ottawa 15
Caltagirone 14
Falls Church 14
Guangzhou 14
Zhengzhou 14
Bremen 12
Redmond 12
San Filippo 12
Padova 11
Taiyuan 11
Nanchang 10
Jiaxing 9
Fuzhou 8
Hangzhou 8
Lanzhou 7
Augusta 6
Leawood 6
Milan 6
Scandicci 6
Tappahannock 6
Aci Sant'antonio 5
Changsha 5
Clearwater 5
Lamezia Terme 5
London 5
Norwalk 5
Reggio Calabria 5
San Giovanni La Punta 5
Cagliari 4
Carini 4
Chicago 4
Enna 4
Kunming 4
Mountain View 4
Auburn Hills 3
Bologna 3
Capo D'orlando 3
Fiumefreddo Di Sicilia 3
Fremont 3
Hefei 3
Jakarta 3
Kemerovo 3
Lappeenranta 3
Misterbianco 3
Montreal 3
Paris 3
Piazza Armerina 3
Pompei 3
Scordia 3
Torino 3
Alexandria 2
Boston 2
Brescia 2
Brisbane 2
Calcinaia 2
Caltanissetta 2
Corte Madera 2
Edinburgh 2
Encinitas 2
Fantina 2
Totale 5.975
Nome #
ADENOSINE RECEPTORS AS STRATEGIC TARGETS FOR THE DESIGN AND DEVELOPMENT OF INNOVATIVE DRUGS FOR THE MANAGEMENT OF SPINAL CORD INJURY 230
Pharmacological activity and clinical use of PDRN 188
β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors 123
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 119
Polydeoxyribonucleotide, an adenosine-A2A receptor agonist, preserves blood testis barrier from cadmium-induced injury 118
Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury 117
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 117
Evidence for a role of mitogen-activated protein kinases in the treatment of experimental acute pancreatitis. 112
Activation of A2A receptor by PDRN Reduces neuronal damage and stimulates WNT/β-CATENIN driven neurogenesis in spinal cord injury 109
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 105
ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury 104
null 102
Blockade of the JNK signalling as a rational therapeutic approach to modulate the early and late steps of the inflammatory cascade in polymicrobial sepsis 100
Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury 100
Oxidative Stress: Harms and Benefits for Human Health 97
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 97
A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury. 96
Apoptotic pathways linked to endocrine system as potential therapeutic targets for benign prostatic hyperplasia 91
Role of Inhibitors of Apoptosis Proteins in Testicular Function and Male Fertility: Effects of Polydeoxyribonucleotide Administration in Experimental Varicocele 89
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 86
Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model 85
Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. 84
NLRP3 Inflammasome Involvement in the Organ Damage and Impaired Spermatogenesis Induced by Testicular Ischemia and Reperfusion in Mice 84
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate 83
null 83
CO2 Pneumoperitoneum Preserves -Arrestin 2 Content and Reduces High Mobility Group Box-1 (HMGB-1) Expression in an Animal Model of Peritonitis 83
Effects of Myo-inositol Alone and in Combination with Seleno-L-methionine on Cadmium-Induced Testicular Damage in Mice 83
Cadmium-induced oxidative stress impairs glycemic control in adolescents 77
CO(2) pneumoperitoneum impact on early liver and lung cytokine expression in a rat model of abdominal sepsis. 76
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 74
Activation of adenosine A2(A) receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice 72
null 71
Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes 71
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 71
Activation of adenosine A2A receptors by polydeoxyribonucleotide increases vascular endothelial growth factor and protects against testicular damage induced by experimental varicocele in rats. 70
Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergicantiinflammatory pathway 70
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 70
Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury 69
Myo-inositol in the protection from cadmium-induced toxicity in mice kidney: An emerging nutraceutical challenge 69
null 67
Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. 67
Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. 67
Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(2A) receptor 66
Dietary management of skin health: The role of genistein 65
Nutraceutical Effects of Lycopene in Experimental Varicocele: An “In Vivo” Model to Study Male Infertility 65
Evidence for using a dual COX 1/2 and 5-LOX inhibitor in neurodegenerative diseases 62
Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. 60
Cadmium delays puberty onset and testis growth in adolescents 60
2017 ACR/ARHP Annual Meeting Abstract Supplement 60
Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice 59
Effects of Soy Isoflavone Genistein Aglycone On Skin Changes Induced By Experimental Menopause : A Comparison With Estradiol And Raloxifene 57
FLAVOCOXID, A DUAL INHIBITOR OF COX-2 AND 5-LOX, REDUCES PANCREATIC DAMAGE IN AN EXPERIMENTAL MODEL OF ACUTE PANCREATITIS. 57
Protective Effects of Myo-Inositol and Selenium on Cadmium-Induced Thyroid Toxicity in Mice 57
Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss of Plakophilin-2 Expression 56
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 55
GENISTEIN AGLYCONE DEMONSTRATES A PROTECTIVE AND REVERSIBLE EFFECT ON THE DEVELOPMENT OF STEROID-INDUCED SECONDARY OSTEOPOROSIS AND INCREASES BONE BREAKING STRENGHT IN VIVO 54
Peroxisome proliferator activated receptor beta/delta activation prevents extracellular regulated kinase 1/2 phosphorylation and protects the testis from ischemia and reperfusion injury. 52
Adenosine receptor stimulation by polynucleotides (PDRN) reduces inflammation in experimental periodontitis. 52
GENISTEIN AGLYCONE IMPROVES SKIN REPAIR IN AN INCISIONAL MODEL OF WOUND HEALING: A COMPARISON WITH RALOXIFENE AND OESTRADIOL IN OVARIECTOMIZED RATS 51
GENISTEIN AGLYCONE: A DUAL MODE OF ACTION ANTI-OSTEOPOROTIC SOY ISOFLAVONE REBALANCING BONE TURNOVER TOWARDS BONE FORMATION 51
Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity 51
Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. 49
Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo 49
Preclinical and clinical applications of biomaterials in the enhancement of wound healing in oral surgery: An overview of the available reviews 49
Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study 48
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis 48
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 48
Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis. 47
Role of cytokines in vitiligo: Pathogenesis and possible targets for old and new treatments 47
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 46
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis 46
A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily 46
Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats 46
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 46
The combination of Serenoa repens, selenium and lycopene ismore effective than Serenoa repens alone to prevent hormonedependent prostatic growth 45
Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene 45
The Association of Myo-Inositol and Selenium Contrasts Cadmium-Induced Thyroid C Cell Hyperplasia and Hypertrophy in Mice 45
Combined treatment with polynucleotides and hyaluronic acid improves tissue repair in experimental colitis 45
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis 45
AB0198 Cilengitide Modulates Pulmonary Cell Proliferation in the Reactive Oxygen Species Murine Model of Systemic Sclerosis 44
MAo-A inhibition by metaxalone reverts IL-1β-induced inflammatory phenotype in microglial cells 44
Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing 44
Effect of Serenoa repens, Lyocopene, and Selenium on Proinflammatory I kappa B-alpha Phenotype Activation: An In Vitro And In Vivo Comparison Study 43
Correction: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis 43
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 43
Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study 43
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 43
Administration of a Nutraceutical Mixture Composed by Aloe arborescens, Annona muricata, Morinda citrifolia, Beta rubra, Scutellaria baicalensis, and Vaccinium myrtillus Reduces Doxorubicin-Induced Side Effects 42
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 42
Health potential of aloe vera against oxidative stress induced corneal damage: An “in vitro” study 42
Reduction of oxidative stress blunts the NLRP3 inflammatory cascade in LPS stimulated human gingival fibroblasts and oral mucosal epithelial cells 42
Serenoa repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia. 41
NLRP3 Inflammasome: A New Pharmacological Target for Reducing Testicular Damage Associated with Varicocele 41
Simvastatin Attenuates Pulmonary Fibrosis in a Murine Model of Systemic Sclerosis. 40
Dual inhibition of cyclooxygenase and 5-lipoxygenase by Flavocoxid protects against kainic acid-induced brain excitotoxicity 40
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 40
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice 40
Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease 40
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 40
Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis 39
Totale 6.752
Categoria #
all - tutte 29.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 19 16 8
2019/2020798 28 10 10 24 8 147 83 58 23 163 110 134
2020/20211.565 104 84 334 91 170 81 101 65 187 209 70 69
2021/20221.305 13 191 30 51 78 31 109 60 27 250 113 352
2022/20232.903 209 301 137 205 184 312 24 176 1.222 18 77 38
2023/2024920 50 124 97 130 73 238 28 45 6 129 0 0
Totale 8.410